4 insiders reported 27 Form 4 transactions for VYNE Therapeutics Inc. (VYNE) over the past 18 months (most recent 2026-07-24). Recent activity: Domzalski David (PRESIDENT AND CEO) Sell 79,391 shares, Stuart Iain (CHIEF SCIENTIFIC OFFICER) Sell 15,405 shares, Harsch Mutya (CHIEF LEGAL OFFICER AND GC) Sell 22,516 shares, Zeronda Tyler (CHIEF FINANCIAL OFFICER) Sell 22,516 shares, Stuart Iain (CHIEF SCIENTIFIC OFFICER) Sell 2,370 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-24 | Domzalski David | PRESIDENT AND CEO | Sell | 79,391 | $71,261 |
| 2026-07-24 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 15,405 | $13,828 |
| 2026-07-24 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 22,516 | $20,210 |
| 2026-07-24 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 22,516 | $20,210 |
| 2026-07-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,370 | $1,542 |
| 2026-07-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,214 | $7,948 |
| 2026-07-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,464 | $2,254 |
| 2026-07-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,464 | $2,254 |
| 2026-06-02 | Domzalski David | PRESIDENT AND CEO | Buy | 30,791 | $9,545 |
| 2026-04-02 | Domzalski David | PRESIDENT AND CEO | Sell | 14,232 | $8,539 |
| 2026-04-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,876 | $1,726 |
| 2026-04-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 4,007 | $2,404 |
| 2026-04-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 4,007 | $2,404 |
| 2026-01-05 | Domzalski David | PRESIDENT AND CEO | Sell | 12,684 | $7,357 |
| 2026-01-05 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,448 | $1,420 |
| 2026-01-05 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,579 | $2,076 |
| 2026-01-05 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 7,858 | $4,558 |
| 2025-10-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $834 |
| 2025-10-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,676 | $4,310 |
| 2025-10-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $1,218 |
| 2025-10-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $1,163 |
| 2025-07-02 | Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sell | 3,581 | $5,909 |
| 2025-07-02 | Zeronda Tyler | CHIEF FINANCIAL OFFICER | Sell | 3,420 | $5,643 |
| 2025-07-02 | Domzalski David | PRESIDENT AND CEO | Sell | 12,676 | $20,915 |
| 2025-07-02 | Stuart Iain | CHIEF SCIENTIFIC OFFICER | Sell | 2,453 | $4,047 |
Source: SEC Form 4 filings · as of 2026-07-24